These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 16269457
1. Intermedin/Adrenomedullin-2 inhibits growth hormone release from cultured, primary anterior pituitary cells. Taylor MM, Bagley SL, Samson WK. Endocrinology; 2006 Feb; 147(2):859-64. PubMed ID: 16269457 [Abstract] [Full Text] [Related]
2. Intermedin functions as a pituitary paracrine factor regulating prolactin release. Lin Chang C, Roh J, Park JI, Klein C, Cushman N, Haberberger RV, Hsu SY. Mol Endocrinol; 2005 Nov; 19(11):2824-38. PubMed ID: 16002435 [Abstract] [Full Text] [Related]
3. Stress hormone secretion is altered by central administration of intermedin/adrenomedullin-2. Taylor MM, Samson WK. Brain Res; 2005 May 31; 1045(1-2):199-205. PubMed ID: 15910778 [Abstract] [Full Text] [Related]
4. Intermedin/adrenomedullin-2 acts within central nervous system to elevate blood pressure and inhibit food and water intake. Taylor MM, Bagley SL, Samson WK. Am J Physiol Regul Integr Comp Physiol; 2005 Apr 31; 288(4):R919-27. PubMed ID: 15576658 [Abstract] [Full Text] [Related]
5. Central neuropeptide B administration activates stress hormone secretion and stimulates feeding in male rats. Samson WK, Baker JR, Samson CK, Samson HW, Taylor MM. J Neuroendocrinol; 2004 Oct 31; 16(10):842-9. PubMed ID: 15500544 [Abstract] [Full Text] [Related]
6. Neuropeptide W acts in brain to control prolactin, corticosterone, and growth hormone release. Baker JR, Cardinal K, Bober C, Taylor MM, Samson WK. Endocrinology; 2003 Jul 31; 144(7):2816-21. PubMed ID: 12810535 [Abstract] [Full Text] [Related]
7. Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion. Samson WK, Keown C, Samson CK, Samson HW, Lane B, Baker JR, Taylor MM. Endocrine; 2003 Jul 31; 20(1-2):59-66. PubMed ID: 12668869 [Abstract] [Full Text] [Related]
8. Adrenomedullin 2/intermedin in the hypothalamo-pituitary-adrenal axis. Takahashi K, Morimoto R, Hirose T, Satoh F, Totsune K. J Mol Neurosci; 2011 Feb 31; 43(2):182-92. PubMed ID: 20596793 [Abstract] [Full Text] [Related]
9. Comparisons between the effects of calcitonin receptor-stimulating peptide and intermedin and other peptides in the calcitonin family on bone resorption and osteoclastogenesis. Granholm S, Henning P, Lerner UH. J Cell Biochem; 2011 Nov 31; 112(11):3300-12. PubMed ID: 21748786 [Abstract] [Full Text] [Related]
10. A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Samson WK, Murphy T, Schell DA. Endocrinology; 1995 May 31; 136(5):2349-52. PubMed ID: 7720684 [Abstract] [Full Text] [Related]
11. Cachectin alters anterior pituitary hormone release by a direct action in vitro. Milenkovic L, Rettori V, Snyder GD, Beutler B, McCann SM. Proc Natl Acad Sci U S A; 1989 Apr 31; 86(7):2418-22. PubMed ID: 2564680 [Abstract] [Full Text] [Related]
12. Molecular characterization of calcitonin gene-related peptide (CGRP) related peptides (CGRP, amylin, adrenomedullin and adrenomedullin-2/intermedin) in goldfish (Carassius auratus): cloning and distribution. Martínez-Alvarez RM, Volkoff H, Cueto JA, Delgado MJ. Peptides; 2008 Sep 31; 29(9):1534-43. PubMed ID: 18539360 [Abstract] [Full Text] [Related]
13. Intermedin 17-47 does not function as a full intermedin antagonist within the central nervous system or pituitary. White MM, Samson WK. Peptides; 2007 Nov 31; 28(11):2171-8. PubMed ID: 17945397 [Abstract] [Full Text] [Related]
14. Dopamine and somatostatin inhibit forskolin-stimulated prolactin and growth hormone secretion but not stimulated cyclic AMP levels in sheep anterior pituitary cell cultures. Ray KP, Gomm JJ, Law GJ, Sigournay C, Wallis M. Mol Cell Endocrinol; 1986 May 31; 45(2-3):175-82. PubMed ID: 2872092 [Abstract] [Full Text] [Related]
15. Stimulatory effect of calcitonin gene-related peptide on adrenocorticotropin release from rat anterior pituitary cells. Iino K, Oki Y, Tominaga T, Iwabuchi M, Ozawa M, Watanabe F, Yoshimi T. J Neuroendocrinol; 1998 May 31; 10(5):325-9. PubMed ID: 9663646 [Abstract] [Full Text] [Related]
16. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension. Zhao Y, Bell D, Smith LR, Zhao L, Devine AB, McHenry EM, Nicholls DP, McDermott BJ. J Pharmacol Exp Ther; 2006 Mar 31; 316(3):1269-81. PubMed ID: 16326922 [Abstract] [Full Text] [Related]
17. Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Samson WK, Taylor MM. Am J Physiol Regul Integr Comp Physiol; 2001 Oct 31; 281(4):R1140-5. PubMed ID: 11557621 [Abstract] [Full Text] [Related]
18. Calcitonin Peptide Family Members Are Differentially Regulated by LPS and Inhibit Functions of Rat Alveolar NR8383 Macrophages. Soultanova A, Mikulski Z, Pfeil U, Grau V, Kummer W. PLoS One; 2016 Oct 31; 11(10):e0163483. PubMed ID: 27737007 [Abstract] [Full Text] [Related]
19. Intermedin enhances sympathetic outflow via receptor-mediated cAMP/PKA signaling pathway in nucleus tractus solitarii of rats. Li P, Sun HJ, Han Y, Wang JJ, Zhang F, Tang CS, Zhou YB. Peptides; 2013 Sep 31; 47():1-6. PubMed ID: 23816795 [Abstract] [Full Text] [Related]
20. Mechanisms involved in the regional haemodynamic effects of intermedin (adrenomedullin 2) compared with adrenomedullin in conscious rats. Jolly L, March JE, Kemp PA, Bennett T, Gardiner SM. Br J Pharmacol; 2009 Aug 31; 157(8):1502-13. PubMed ID: 19681873 [Abstract] [Full Text] [Related] Page: [Next] [New Search]